콜마바이오텍

215380KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

2,125KRWMarket close of 10/29 (Thu)

Down -0.70%-15KRWMarket close of 10/29 (Thu)

Open
2,140
High
2,155
Low
2,080
Day range
Day range low 2,080 high 2,155, open 2,140, close 2,125, previous close 2,140
Volume
1×10K shares
31.35 million KRW 0.14× the 20-session average

Market close of 10/29 (Thu)

Where it sits in the 1-year range

1-year close range 1,714 to 3,605 won, 22% up from the low

22% of the way up from the lowest close in 1 year (252 sessions) · -41.1% from the high

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/29 (Thu)
Market close data of 2026-10-29

Points to check

  • Earningsnot verifiedThe last four quarters are incomplete, so not verified
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 2 are within the usual range

  • Daily move-0.70%usual range
  • Trading value0.1×usual range
See the full check report

Filings in the last 2 years · 1

Annual reportHalf-year reportQuarterly reportMaterial eventAmended

Material events are checked for the top 400 stocks only — this stock shows periodic reports only.

  1. 2026-08-14Half-year report (2026.06)

Same sector · 바이오 R&D

Down -1.23%

· 9 of 64 stocks up, preferred shares excluded · trading value 195.6B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -13.6%Down -1.35%51.8B KRW
SK바이오팜Close over the last 20 sessions +4.6%Up +3.46%16.0B KRW
디앤디파마텍Close over the last 20 sessions -0.4%Down -2.80%15.7B KRW
올릭스Close over the last 20 sessions -5.9%Down -0.82%14.9B KRW
리가켐바이오Close over the last 20 sessions -19.8%Down -3.32%14.5B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 17 days
  • Next data 11/2 (Mon) after 08:50

Related news

All news
Loading

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 86% of trading value, about 93% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.